At Aiosyn we are convinced that computational pathology empowers pathologists to make their work more accurate, efficient and effective. We develop software solutions that inject deep-learning algorithms into existing pathologist workflows to improve clinical decision-making.
With our AI-powered technology, we want to provide new perspectives that lead to improved patient identification and stratification in drug development programs.
Aiosyn was founded as a spin-off from the Computational Pathology research group of Radboud University Medical Center, one of the front-runners in the field. We build upon 20+ years of research experience in the field of pathology and are proud to say that we are rooted in pathology practice. With our track-record in artificial intelligence and software engineering we bring research innovations into the hands of pathologists.
Our close connection to clinical practice allows us to build computational pathology solutions for and together with pathologists. We believe in the power of AI to empower pathologists and envision a world where AI is available everywhere, anytime.